0000899243-18-012080.txt : 20180509 0000899243-18-012080.hdr.sgml : 20180509 20180509161444 ACCESSION NUMBER: 0000899243-18-012080 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180507 FILED AS OF DATE: 20180509 DATE AS OF CHANGE: 20180509 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Grossi Federico CENTRAL INDEX KEY: 0001720634 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38276 FILM NUMBER: 18818434 MAIL ADDRESS: STREET 1: C/O APELLIS PHARMACEUTICALS, INC. STREET 2: 6400 WESTWIND WAY, SUITE A CITY: CRESTWOOD STATE: KY ZIP: 40014 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Apellis Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001492422 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 271537290 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 6400 WESTWIND WAY STREET 2: SUITE A CITY: CRESTWOOD STATE: KY ZIP: 40014 BUSINESS PHONE: 502-241-4114 MAIL ADDRESS: STREET 1: 6400 WESTWIND WAY STREET 2: SUITE A CITY: CRESTWOOD STATE: KY ZIP: 40014 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2018-05-07 0 0001492422 Apellis Pharmaceuticals, Inc. APLS 0001720634 Grossi Federico C/O APELLIS PHARMACEUTICALS, INC 6400 WESTWIND WAY, SUITE A CRESTWOOD KY 40014 0 1 0 0 See Remarks Common Stock 2018-05-07 4 J 0 7706 0.00 A 16206 D Distribution from Potentia Holdings, LLC, of which the reporting person is a non-managing member. Executive Vice President - Clinical Development /s/ David Watson, attorney-in-fact for Federico Grossi 2018-05-08